Ritter Pharmac. Com (RTTR) Stock Overview
USA - NASDAQ:RTTR -
RTTR Key Statistics, Chart & Performance
The current stock price of RTTR is 0.448 null. In the past month the price increased by 24.62%. In the past year, price decreased by -45.37%.
RTTR Latest News, Press Relases and Analysis
About RTTR
Company Profile
Ritter Pharmaceuticals, Inc. is involved in developing therapeutic products to treat inflammatory, gastrointestinal and metabolic diseases. Its lead product candidate is RP-G28, a novel microbiome modulator, which is under development for the reduction of symptoms associated with lactose intolerance. Ritter Pharmaceuticals, Inc. is headquartered in Los Angeles, California.
Company Info
Ritter Pharmac. Com
1880 CENTURY PARK EAST SUITE 1000
LOS ANGELES CA 90067
CEO: Andrew J. Ritter
Phone: 310-203-1000
Ritter Pharmac. Com / RTTR FAQ
What is the stock price of Ritter Pharmac. Com today?
The current stock price of RTTR is 0.448 null. The price increased by 1.82% in the last trading session.
What is the ticker symbol for Ritter Pharmac. Com stock?
The exchange symbol of Ritter Pharmac. Com is RTTR and it is listed on the Nasdaq exchange.
On which exchange is RTTR stock listed?
RTTR stock is listed on the Nasdaq exchange.
What is Ritter Pharmac. Com worth?
Ritter Pharmac. Com (RTTR) has a market capitalization of 20.68M null. This makes RTTR a Nano Cap stock.
What are the support and resistance levels for Ritter Pharmac. Com (RTTR) stock?
Ritter Pharmac. Com (RTTR) has a support level at 0.44 and a resistance level at 0.7. Check the full technical report for a detailed analysis of RTTR support and resistance levels.
Should I buy Ritter Pharmac. Com (RTTR) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of RTTR, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of RTTR, evaluating the profitability, health, valuation and growth aspects
- Ritter Pharmac. Com (RTTR) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Ritter Pharmac. Com (RTTR) Sales and EPS estimates to see what analysts future expectations are.
- Ritter Pharmac. Com (RTTR) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Ritter Pharmac. Com (RTTR) Insider and Institutional Ownership to learn about the owners and their transactions.
- Ritter Pharmac. Com (RTTR) Stock Chart to make your own analysis
- Ritter Pharmac. Com (RTTR) Latest news and press-releases to stay up to date.
Does Ritter Pharmac. Com (RTTR) stock pay dividends?
RTTR does not pay a dividend.
What is the Price/Earnings (PE) ratio of Ritter Pharmac. Com (RTTR)?
Ritter Pharmac. Com (RTTR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.64).
RTTR Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to RTTR. When comparing the yearly performance of all stocks, RTTR is one of the better performing stocks in the market, outperforming 89.94% of all stocks.
RTTR Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to RTTR. RTTR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
RTTR Financial Highlights
Over the last trailing twelve months RTTR reported a non-GAAP Earnings per Share(EPS) of -0.64. The EPS increased by 83.07% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -106.09% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |